» Articles » PMID: 35845835

DeepND: Deep Multitask Learning of Gene Risk for Comorbid Neurodevelopmental Disorders

Overview
Journal Patterns (N Y)
Date 2022 Jul 18
PMID 35845835
Authors
Affiliations
Soon will be listed here.
Abstract

Autism spectrum disorder and intellectual disability are comorbid neurodevelopmental disorders with complex genetic architectures. Despite large-scale sequencing studies, only a fraction of the risk genes was identified for both. We present a network-based gene risk prioritization algorithm, DeepND, that performs cross-disorder analysis to improve prediction by exploiting the comorbidity of autism spectrum disorder (ASD) and intellectual disability (ID) via multitask learning. Our model leverages information from human brain gene co-expression networks using graph convolutional networks, learning which spatiotemporal neurodevelopmental windows are important for disorder etiologies and improving the state-of-the-art prediction in single- and cross-disorder settings. DeepND identifies the prefrontal and motor-somatosensory cortex (PFC-MFC) brain region and periods from early- to mid-fetal and from early childhood to young adulthood as the highest neurodevelopmental risk windows for ASD and ID. We investigate ASD- and ID-associated copy-number variation (CNV) regions and report our findings for several susceptibility gene candidates. DeepND can be generalized to analyze any combinations of comorbid disorders.

Citing Articles

Proximity analysis of native proteomes reveals phenotypic modifiers in a mouse model of autism and related neurodevelopmental conditions.

Gao Y, Shonai D, Trn M, Zhao J, Soderblom E, Garcia-Moreno S Nat Commun. 2024; 15(1):6801.

PMID: 39122707 PMC: 11316102. DOI: 10.1038/s41467-024-51037-x.


Graph Node Classification to Predict Autism Risk in Genes.

Bandara D, Riccardi K Genes (Basel). 2024; 15(4).

PMID: 38674382 PMC: 11049455. DOI: 10.3390/genes15040447.


Deep Learning for Genomics: From Early Neural Nets to Modern Large Language Models.

Yue T, Wang Y, Zhang L, Gu C, Xue H, Wang W Int J Mol Sci. 2023; 24(21).

PMID: 37958843 PMC: 10649223. DOI: 10.3390/ijms242115858.


Phenotypic Trade-Offs: Deciphering the Impact of Neurodiversity on Drug Development in Fragile X Syndrome.

Bui T, Shatto J, Cuppens T, Droit A, Bolduc F Front Psychiatry. 2021; 12:730987.

PMID: 34733188 PMC: 8558248. DOI: 10.3389/fpsyt.2021.730987.


Prioritizing de novo autism risk variants with calibrated gene- and variant-scoring models.

Jiang Y, Urresti J, Pagel K, Pramod A, Iakoucheva L, Radivojac P Hum Genet. 2021; 141(10):1595-1613.

PMID: 34549350 PMC: 8938308. DOI: 10.1007/s00439-021-02356-2.

References
1.
ORoak B, Vives L, Girirajan S, Karakoc E, Krumm N, Coe B . Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature. 2012; 485(7397):246-50. PMC: 3350576. DOI: 10.1038/nature10989. View

2.
Anney R, Klei L, Pinto D, Almeida J, Bacchelli E, Baird G . Individual common variants exert weak effects on the risk for autism spectrum disorders. Hum Mol Genet. 2012; 21(21):4781-92. PMC: 3471395. DOI: 10.1093/hmg/dds301. View

3.
Bayes A, van de Lagemaat L, Collins M, Croning M, Whittle I, Choudhary J . Characterization of the proteome, diseases and evolution of the human postsynaptic density. Nat Neurosci. 2010; 14(1):19-21. PMC: 3040565. DOI: 10.1038/nn.2719. View

4.
Liu L, Lei J, Sanders S, Willsey A, Kou Y, Cicek A . DAWN: a framework to identify autism genes and subnetworks using gene expression and genetics. Mol Autism. 2014; 5(1):22. PMC: 4016412. DOI: 10.1186/2040-2392-5-22. View

5.
Neale B, Kou Y, Liu L, Maayan A, Samocha K, Sabo A . Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature. 2012; 485(7397):242-5. PMC: 3613847. DOI: 10.1038/nature11011. View